
Dabitan 110mg Tablet
Marketer
Saanso Pharma Private Limited
Salt Composition
Dabigatran Etexilate (110mg)
Overview Dabitan 110mg Tablet
Edoxaban 110mg tablets function as an anticoagulant, preventing and treating blood clots. This medication lowers the risk of stroke and heart attack by inhibiting clot formation in leg, lung, brain, and heart veins. Frequently prescribed for individuals with atrial fibrillation (irregular heartbeat), it also mitigates clot risk post-knee or hip replacement. Dosage can be administered with or without food, but consistent daily timing is recommended. Long-term use, sometimes lifelong, may be necessary; discontinuation or dosage alteration requires physician consultation to avoid increased stroke, heart attack, or thrombosis risk. Lifestyle modifications such as diet, exercise, smoking cessation, and weight management further reduce clot risk. Common side effects include gastrointestinal discomfort and increased bleeding susceptibility (e.g., nosebleeds, bruising). Report any adverse effects promptly. Other potential side effects encompass headaches, seizures, allergic reactions, visual disturbances, and fatigue. Contraindications include severe hepatic or renal impairment, active bleeding, and concurrent use of other anticoagulants. Breastfeeding is not advised during treatment. Unlike some anticoagulants, routine PT-INR monitoring isn't typically needed.
Uses of Dabitan 110mg Tablet
Preventing and managing blood clots.
Major Benefits of Dabitan 110mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dabitan 110mg Tablets can be consumed with or without food; however, consistent daily timing is recommended.
Common Side effects of Dabitan 110mg Tablet:
- Nausea
- Anemia (low number of red blood cells)
- Gastrointestinal bleeding
- Dyspepsia
- Diarrhea
- Abdominal pain
- Nosebleeds
- Skin bleeding
How to use Dabitan 110mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dabitan 110mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Dabitan 110mg Tablet works:
A novel oral anticoagulant, Dabitan 110mg tablets, inhibits blood clot development.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Dabitan 110mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dabitan 110mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against potential dangers prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Administration of Dabitan 110mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Dabitan 110mg tablets.
KidneyCAUTION
Individuals with severely impaired kidney function should exercise caution when using Dabitan 110mg tablets, as dose modification may be necessary. A physician's consultation is advised. Dabitan 110mg tablets are contraindicated in patients exhibiting severe renal impairment.
LiverCAUTION
Patients with liver impairment should exercise caution when taking Dabitan 110mg tablets. Dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Dabitan 110mg Tablet :
Should you forget a Dabitan 110mg Tablet dose, ingest it immediately upon remembrance that day. However, omit the missed dose if ingestion is impossible at least six hours prior to your next planned dose. Never compensate for a missed dose by taking a double dose.
Facts to Know About Dabitan 110mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole-based compound |
| Developing Good Habits | No. |
| Treatment Category | Heart |
| Actions | Oral direct thrombin inhibitor |
